Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates
The in vitro activities of tigecycline against 1,924 clinical isolates were examined. The new glycylcycline exhibited excellent activity against all gram-positive cocci (MICs at which 90% of the isolates tested were inhibited [MIC(90)s], ≤1 μg/ml). In addition, it was also very potent against most m...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
2003
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149011/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499224/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.400-404.2003 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|